Related Experiment Video
Updated: Oct 2, 2025

08:58
Label-Free Identification of Lymphocyte Subtypes Using Three-Dimensional Quantitative Phase Imaging and Machine Learning
Published on: November 19, 2018
12.7K
A hybrid deep learning model for forecasting lymphocyte depletion during radiation therapy
Saba Ebrahimi1, Gino Lim1, Brian P Hobbs2
1Department of Industrial Engineering, University of Houston, Houston, Texas, USA.
Medical Physics
|March 1, 2022
Summary
A new deep learning model accurately predicts radiation-induced lymphocyte depletion in esophageal cancer patients. This tool helps personalize radiation therapy (RT) by identifying patients at high risk for lymphopenia.
Area of Science:
- Oncology
- Radiotherapy
- Artificial Intelligence
Background:
- Severe depletion of absolute lymphocyte count (ALC) during radiation therapy (RT) is linked to poorer survival in solid tumors.
- Predicting RT-induced lymphocyte depletion is crucial for optimizing treatment plans.
Purpose of the Study:
- To develop a predictive model for radiation-induced lymphocyte depletion in esophageal cancer patients.
- To utilize patient characteristics and dosimetric features for early prediction of ALC trends during RT.
Main Methods:
- A hybrid deep learning model with a stacked structure, incorporating Long Short-Term Memory (LSTM) and neural networks.
- The model processes four feature categories through separate channels, integrating outputs for weekly ALC prediction.
- A discriminative kernel was employed to extract temporal features and assign weights to input sequences.
Main Results:
- The proposed model demonstrated superior performance compared to existing prediction methods.
- A 30% reduction in Mean Squared Error (MSE) for weekly ALC predictions using pre-treatment data was achieved.
- An extended model using first-week treatment data further reduced MSE by 70% compared to pre-treatment data.
Conclusions:
- The developed model effectively predicts radiation-induced lymphocyte depletion for RT planning.
- Predicting ALC enables physicians to assess lymphopenia risk and identify patients for treatment modification.
- This facilitates personalized RT strategies to mitigate adverse outcomes associated with lymphocyte depletion.

